For more than a decade, REV•1 Engineering® has been delivering innovative solutions to leading edge, global medical device companies. With industry average experience of more than 20 years, our team of 20+ engineers and technicians has been instrumental in developing novel technologies and delivery systems for complex, interventional therapies that have demonstrated exponential value creation in the marketplace. REV.1 was recently acquired by ASAHI INTECC and operates as a subsidiary of ASAHI Filmecc. REV•1 has extensive experience and expertise in: ~ Structural Heart and Delivery Systems. ~ Interventional Cardiology. ~ Drug/Device/Biologics Combination Products. ~ Neuromodulation Devices. ~ Catheter Navigation, Delivery and Anchoring Systems. ~ Design for Manufacture & Design Transfer. ~ Rapid Operational Improvements (Profitability of Current Manufacturing Lines). ~ Remediation (Engineering & Documentation). Over this period, our team has successfully developed more than 140 devices for more than 70 client companies, many of which were startups working with highly constrained budgets and tight deadlines. The demands of this challenging environment tempered REV•1 into an efficient and efficacious medical device development and innovation company. One that has consistently demonstrated we’re 2X Faster than in-house development. Our speed to market, and revenue, delivers a distinct, competitive and financial advantage to our clients.